View Author
scopus: 8597653400

Kaper, J.

(Janneke kaper)


reimbursement scenario smoking health trial-based reimbursement scenario cessation smoker intervention literature-based reimbursement scenario trial health care costs effect study reference scenario life years smoking cessation support trial-based number smoking cessation netherland policy difference literature-based reference month disease addiction dutch intervention costs control group group model support estimate period reimbursement policy control addiction addiction result –utility outcome cost –utility sensitivity analyses 20 years author society cessation support percentage analyses 6 months hoogenveen effectiveness sensitivity pilot study trial-based scenario reimbursement period cessation rates 1088–1097 table disease model horizon quitter institute compilation journal 12 months intervention group health care insurance cost –utility ratios population nicotine replacement therapy abstinence ratio health care perspective tobacco smoking cessation treatment health gains attempt health effects cost-effectiveness




2 Most Recent Publications

Productivity cost calculations in health economic evaluations: Correcting for compensation mechanisms and multiplier effects (Article)
Krol, H.M. Brouwer, W.B.F. Severens, J.L. Kaper, J. Evers, S.M.A.A.
2012-12-01
If you try to stop smoking, should we pay for it? The cost-utility of reimbursing smoking cessation support in the Netherlands (Article)
Vemer, P. Rutten-van Mölken, M.P.M.H. Kaper, J. Hoogenveen, R.T. Schayck, C.P. van Feenstra, T.L.
2010-06-01